195 related articles for article (PubMed ID: 31711153)
1. Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
Chen S; Redfors B; Nazif T; Kirtane A; Crowley A; Ben-Yehuda O; Kapadia S; Finn MT; Goel S; Lindman BR; Alu MC; Chau KH; Thourani VH; Vahl TP; Douglas PS; Kodali SK; Leon MB
Eur Heart J; 2020 Feb; 41(8):943-954. PubMed ID: 31711153
[TBL] [Abstract][Full Text] [Related]
2. Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data.
Cubeddu RJ; Murphy SME; Asher CR; Garcia SA; Granada JF; Don CW; Patel S; Albaghdadi MS; Cavalcante JL; Coylewright M; Hahn RT; Genereux P; Yadav PK; Thourani VH; Leon MB
Am Heart J; 2023 Apr; 258():27-37. PubMed ID: 36596333
[TBL] [Abstract][Full Text] [Related]
3. Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries.
Chen S; Redfors B; Crowley A; Ben-Yehuda O; Summers M; Hahn RT; Jaber WA; Pibarot P; Alu MC; Chau KH; Kapadia S; Nazif T; Vahl TP; Thourani V; Kodali S; Leon M
Eur J Heart Fail; 2020 Oct; 22(10):1866-1874. PubMed ID: 32441856
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system inhibitors reduce cardiovascular mortality in hypertensive patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry.
Basile C; Mancusi C; Franzone A; Avvedimento M; Bardi L; Angellotti D; Castiello DS; Mariani A; Manzo R; De Luca N; Cirillo P; De Simone G; Esposito G
Front Cardiovasc Med; 2023; 10():1234368. PubMed ID: 37692038
[TBL] [Abstract][Full Text] [Related]
5. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
Chen S; Redfors B; O'Neill BP; Clavel MA; Pibarot P; Elmariah S; Nazif T; Crowley A; Ben-Yehuda O; Finn MT; Alu MC; Vahl TP; Kodali S; Leon MB; Lindman BR
Eur Heart J; 2020 Feb; 41(8):958-969. PubMed ID: 31883339
[TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
[TBL] [Abstract][Full Text] [Related]
7. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation.
Ochiai T; Saito S; Yamanaka F; Shishido K; Tanaka Y; Yamabe T; Shirai S; Tada N; Araki M; Naganuma T; Watanabe Y; Yamamoto M; Hayashida K
Heart; 2018 Apr; 104(8):644-651. PubMed ID: 28986405
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.
Rodriguez-Gabella T; Catalá P; Muñoz-García AJ; Nombela-Franco L; Del Valle R; Gutiérrez E; Regueiro A; Jimenez-Diaz VA; Ribeiro HB; Rivero F; Fernandez-Diaz JA; Pibarot P; Alonso-Briales JH; Tirado-Conte G; Moris C; Diez Del Hoyo F; Jiménez-Britez G; Zaderenko N; Alfonso F; Gómez I; Carrasco-Moraleja M; Rodés-Cabau J; San Román Calvar JA; Amat-Santos IJ
J Am Coll Cardiol; 2019 Aug; 74(5):631-641. PubMed ID: 31370954
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
Martinsson A; Törngren C; Nielsen SJ; Pan E; Hansson EC; Taha A; Jeppsson A
Heart; 2024 Jan; 110(3):202-208. PubMed ID: 37460192
[TBL] [Abstract][Full Text] [Related]
11. Relation Between Renin-Angiotensin System Blockers and Survival Following Isolated Aortic Valve Replacement for Aortic Stenosis.
Magne J; Guinot B; Le Guyader A; Bégot E; Marsaud JP; Mohty D; Aboyans V
Am J Cardiol; 2018 Feb; 121(4):455-460. PubMed ID: 29254679
[TBL] [Abstract][Full Text] [Related]
12. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.
Raposeiras-Roubín S; Abu-Assi E; Cespón-Fernández M; Ibáñez B; García-Ruiz JM; D'Ascenzo F; Simao Henriques JP; Saucedo J; Caneiro-Queija B; Cobas-Paz R; Muñoz-Pousa I; Wilton SB; González Juanatey JR; Kikkert WJ; Núñez-Gil I; Ariza-Solé A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Gaita F; Huczek Z; Nie SP; Yan Y; Fujii T; Correia L; Kawashiri MA; Kedev S; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Kowara M; Filipiak K; Wang X; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):114-122. PubMed ID: 31105064
[TBL] [Abstract][Full Text] [Related]
13. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
[TBL] [Abstract][Full Text] [Related]
14. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
[TBL] [Abstract][Full Text] [Related]
15. Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke.
Makkar RR; Yoon SH; Leon MB; Chakravarty T; Rinaldi M; Shah PB; Skipper ER; Thourani VH; Babaliaros V; Cheng W; Trento A; Vemulapalli S; Kapadia SR; Kodali S; Mack MJ; Tang GHL; Kaneko T
JAMA; 2019 Jun; 321(22):2193-2202. PubMed ID: 31184741
[TBL] [Abstract][Full Text] [Related]
16. Impact of renin-angiotensin-aldosterone system inhibition on morbidity and mortality during long-term continuous-flow left ventricular assist device support: An IMACS report.
Brinkley DM; Wang L; Yu C; Grandin EW; Kiernan MS
J Heart Lung Transplant; 2021 Dec; 40(12):1605-1613. PubMed ID: 34663529
[TBL] [Abstract][Full Text] [Related]
17. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
[TBL] [Abstract][Full Text] [Related]
18. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
[TBL] [Abstract][Full Text] [Related]
19. Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk.
Makkar RR; Yoon SH; Chakravarty T; Kapadia SR; Krishnaswamy A; Shah PB; Kaneko T; Skipper ER; Rinaldi M; Babaliaros V; Vemulapalli S; Trento A; Cheng W; Kodali S; Mack MJ; Leon MB; Thourani VH
JAMA; 2021 Sep; 326(11):1034-1044. PubMed ID: 34546301
[TBL] [Abstract][Full Text] [Related]
20. New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.
Nazif TM; Chen S; George I; Dizon JM; Hahn RT; Crowley A; Alu MC; Babaliaros V; Thourani VH; Herrmann HC; Smalling RW; Brown DL; Mack MJ; Kapadia S; Makkar R; Webb JG; Leon MB; Kodali SK
Eur Heart J; 2019 Jul; 40(27):2218-2227. PubMed ID: 31505615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
